Literature DB >> 23391837

Combined treatment of brain AVMs with use of Onyx embolization followed by radiosurgery.

L Pierot1, K Kadziolka, F Litré, P Rousseaux.   

Abstract

BACKGROUND AND
PURPOSE: The treatment of cerebral AVMs is complex, reliant on interventions such as embolization, surgery, and radiosurgery, or a combination of these modalities. To date, treatment with the embolic agent Onyx, followed by radiosurgery, has not been evaluated. The goal of this study was to evaluate the safety and efficacy of this combination in a homogeneous, monocentric series.
MATERIALS AND METHODS: From April 2003 to June 2008, a total of 20 patients (11 women and 9 men; age range, 10-55 years) were treated for AVMs with Onyx embolization followed by radiosurgery. AVM sizes were <3 cm in 7 patients and ≥3 cm in 13 patients. Modalities and complications of the procedure were analyzed as well as the long-term clinical and anatomic outcomes (2-5 years after treatment).
RESULTS: Of 17 patients evaluated by DSA after radiosurgery, 10 (58.8%) were observed to have complete occlusion of the AVM nidus. Complete occlusion was observed in 5 (71.4%) of 7 Spetzler-Martin grade I-II AVMs and in 5 (50.0%) of 10 Spetzler-Martin grade III-IV AVMs. Complete occlusion was observed in 4 (80.0%) of 5 AVMs of <3 cm and 6 (50.0%) of 12 AVMs of >3 cm. One of 20 patients had significant worsening of clinical status (mRS ≥2) at long-term follow-up.
CONCLUSIONS: In this preliminary series, the safety and efficacy of combined treatment by Onyx embolization followed by radiosurgery are quite satisfactory, with a low rate of clinical complications (5.0%) and a 58.8% rate of complete obliteration of the AVM.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23391837      PMCID: PMC8051478          DOI: 10.3174/ajnr.A3409

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  14 in total

1.  Radiosurgical treatment planning of AVM following embolization with Onyx: possible dosage error in treatment planning can be averted.

Authors:  Natan Shtraus; Dan Schifter; Benjamin W Corn; Shimon Maimon; Shlomi Alani; Vladimir Frolov; Diana Matceyevsky; Andrew A Kanner
Journal:  J Neurooncol       Date:  2010-04-10       Impact factor: 4.130

2.  Onyx embolization for the treatment of brain arteriovenous malformations.

Authors:  Feng Xu; Wei Ni; Yujun Liao; Yuxiang Gu; Bin Xu; Bing Leng; Donglei Song
Journal:  Acta Neurochir (Wien)       Date:  2010-10-28       Impact factor: 2.216

3.  Effect of liquid embolic agents on Gamma Knife surgery dosimetry for arteriovenous malformations. Clinical article.

Authors:  Maria Mamalui-Hunter; Thomas Jiang; Keith M Rich; Colin P Derdeyn; Robert E Drzymala
Journal:  J Neurosurg       Date:  2011-04-15       Impact factor: 5.115

4.  A prospective, multicenter, randomized trial of the Onyx liquid embolic system and N-butyl cyanoacrylate embolization of cerebral arteriovenous malformations. Clinical article.

Authors:  Yince Loh; Gary R Duckwiler
Journal:  J Neurosurg       Date:  2010-10       Impact factor: 5.115

5.  Embolization before radiosurgery reduces the obliteration rate of arteriovenous malformations.

Authors:  Yuri M Andrade-Souza; Meera Ramani; Daryl Scora; May N Tsao; Karel terBrugge; Michael L Schwartz
Journal:  Neurosurgery       Date:  2007-03       Impact factor: 4.654

6.  Combined endovascular embolization and stereotactic radiosurgery in the treatment of large arteriovenous malformations.

Authors:  Spiros L Blackburn; William W Ashley; Keith M Rich; Joseph R Simpson; Robert E Drzymala; Wilson Z Ray; Christopher J Moran; DeWitte T Cross; Michael R Chicoine; Ralph G Dacey; Colin P Derdeyn; Gregory J Zipfel
Journal:  J Neurosurg       Date:  2011-02-18       Impact factor: 5.115

7.  A proposed grading system for arteriovenous malformations.

Authors:  R F Spetzler; N A Martin
Journal:  J Neurosurg       Date:  1986-10       Impact factor: 5.115

8.  Risk of hemorrhage and obliteration rates of LINAC-based radiosurgery for cerebral arteriovenous malformations treated after prior partial embolization.

Authors:  Angelika Zabel-du Bois; Stefanie Milker-Zabel; Peter Huber; Wolfgang Schlegel; Jürgen Debus
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-03-29       Impact factor: 7.038

9.  Treatment of arteriovenous malformations using Gamma Knife surgery: the experience at the University of Washington from 2000 to 2005.

Authors:  James G Douglas; Robert Goodkin
Journal:  J Neurosurg       Date:  2008-12       Impact factor: 5.115

10.  Retrospective analysis of unstaged and staged Gamma Knife surgery with and without preceding embolization for the treatment of arteriovenous malformations.

Authors:  Adam G Back; Dennis Vollmer; Otto Zeck; Clive Shkedy; Peter M Shedden
Journal:  J Neurosurg       Date:  2008-12       Impact factor: 5.115

View more
  16 in total

1.  Preliminary experience with precipitating hydrophobic injectable liquid in brain arteriovenous malformations.

Authors:  Naci Koçer; Hakan Hanımoğlu; Şebnem Batur; Sedat Giray Kandemirli; Osman Kızılkılıç; Zihni Sanus; Büge Öz; Civan Işlak; Mehmet Yaşar Kaynar
Journal:  Diagn Interv Radiol       Date:  2016 Mar-Apr       Impact factor: 2.630

2.  Targeted embolization reduces hemorrhage complications in partially embolized cerebral AVM combined with gamma knife surgery.

Authors:  Huo Xiaochuan; Jiang Yuhua; Lv Xianli; Yang Hongchao; Zhao Yang; Li Youxiang
Journal:  Interv Neuroradiol       Date:  2015-02       Impact factor: 1.610

3.  Combined treatment approach to cerebral arteriovenous malformation in pediatric patients: stereotactic radiosurgery to partially Onyx-embolized AVM.

Authors:  Daniel Umansky; Benjamin W Corn; Ido Strauss; Natan Shtraus; Shlomi Constantini; Vladimir Frolov; Shimon Maimon; Andrew A Kanner
Journal:  Childs Nerv Syst       Date:  2018-06-07       Impact factor: 1.475

4.  Endovascular treatment of brain arteriovenous malformations using a liquid embolic agent: results of a prospective, multicentre study (BRAVO).

Authors:  L Pierot; C Cognard; D Herbreteau; H Fransen; W J van Rooij; E Boccardi; A Beltramello; N Sourour; K Kupcs; A Biondi; A Bonafé; W Reith; A Casasco
Journal:  Eur Radiol       Date:  2013-05-08       Impact factor: 5.315

5.  Predictors for occlusion of cerebral AVMs following radiation therapy : Radiation dose and prior embolization, but not Spetzler-Martin grade.

Authors:  Stefan Knippen; Florian Putz; Sabine Semrau; Ulrike Lambrecht; Arzu Knippen; Michael Buchfelder; Sven Schlaffer; Tobias Struffert; Rainer Fietkau
Journal:  Strahlenther Onkol       Date:  2016-10-18       Impact factor: 3.621

6.  Will a randomized trial of unruptured brain arteriovenous malformations change our clinical practice?

Authors:  L Pierot; J Fiehler; C Cognard; M Söderman; L Spelle
Journal:  AJNR Am J Neuroradiol       Date:  2014-01-16       Impact factor: 3.825

7.  Acute management of brain arteriovenous malformations.

Authors:  Andreas Hartmann; J P Mohr
Journal:  Curr Treat Options Neurol       Date:  2015-05       Impact factor: 3.598

8.  Value of 4D MR angiography at 3T compared with DSA for the follow-up of treated brain arteriovenous malformation.

Authors:  S Soize; F Bouquigny; K Kadziolka; C Portefaix; L Pierot
Journal:  AJNR Am J Neuroradiol       Date:  2014-06-05       Impact factor: 3.825

9.  Current surgical results with low-grade brain arteriovenous malformations.

Authors:  Matthew B Potts; Darryl Lau; Adib A Abla; Helen Kim; William L Young; Michael T Lawton
Journal:  J Neurosurg       Date:  2015-02-06       Impact factor: 5.115

10.  Dosimetric effects of embolization material artefacts in arteriovenous malformations stereotactic radiosurgery on treatment planning calculation.

Authors:  Abousaleh Elawadi; Mukhtar Alshanqity; Hussain AlHussain; Reham Mohamed; Yasser Orz; Sultan Alqahtani; Sayel Melheim
Journal:  Phys Imaging Radiat Oncol       Date:  2022-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.